Antibody Characterization
of recombinant monoclonal antibodies
Do you need sequence confirmation of a monoclonal ab?
Are you tired of waiting months for analysis results?
We provide optimized IgG analyses for early discovery, process development, and pharmacokinetics/pharmadynamics of monoclonal antibody-based pharmaceuticals.
Our antibody analyses include:
- Heavy and light chain Mw determination by mass spectrometry
- Peptide mapping by mass spectrometry of heavy and light chain
- N- and C-terminal sequencing of heavy and light chain by MALDI ISD
- Edman N-terminal sequencing
- CDR sequencing of variable complementary determining regions
- 1D SDS PAGE and 2D PAGE electrophoresis
- Post translational modification analysis; deamidation, oxidation, pyroglutamate, N-glycosylation
- Antibody quantification assay by LC MS/MS
- Host Cell Protein (HCP) identification assay
Contact us to discuss your antibody characterization in more detail and we will provide a project proposal with analysis description, timelines and costs.



Follow us on: